Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02930902
Title Preoperative Pilot Study to Assess Safety and Immunological Effect of Pembrolizumab (Keytruda) in Combination With Paricalcitol With or Without Chemotherapy in Patients With Resectable Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

pancreatic carcinoma

Therapies

Paricalcitol + Pembrolizumab

Gemcitabine + Nab-paclitaxel + Paricalcitol + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.